Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well temsirolimus works in treating patients with endometrial
cancer that has spread to other parts of the body or has spread from where it started to
nearby tissue or lymph nodes and has come back after a period of time during which the cancer
could not be detected. Temsirolimus may stop the growth of tumor cells by blocking some of
the enzymes needed for cell growth.